GATA2 and prostate cancer: Further evidence for the GATA2 gene being an important regulatory gene in prostate cancer is the finding that the silencing of the GATA2 gene in LNCaP cells led to significantly changed expression of as many as 2400 genes (>2 fold change, FDR <0.05; Table 1).